Ind-Swift Labs allots 70 lakh convertible warrants to promoter group entity at Rs 196
INDSWFTLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.9 pts less than Nifty Microcap 250 and 1.9 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Ind-Swift Laboratories has allotted 70 lakh fully convertible warrants to Essix Biosciences Limited, a promoter group entity, on preferential basis at Rs 196 per warrant (including Rs 186 premium). Company received 25 percent upfront payment of Rs 49 per warrant, totaling Rs 34.30 crore. Total potential conversion value stands at about Rs 137.2 crore. Allotment follows shareholder approval dated August 5, 2026 and in-principle approval from BSE and NSE.
Promoter group is infusing capital, signaling confidence. May lead to equity dilution when warrants are exercised.